LC–MS/MS and NMR Characterization of Key Impurities in Linagliptin and Pramipexole-Reference-Cited by-同舟云学术

LC–MS/MS and NMR Characterization of Key Impurities in Linagliptin and Pramipexole

Published:2015-11-13 Issue:19 Volume:38 Page:1699-1712
ISSN:1082-6076
Container-title:Journal of Liquid Chromatography & Related Technologies
language:en
Short-container-title:Journal of Liquid Chromatography & Related Technologies

Author:

Parsha Swetha¹²,Kumar Y. Ravindra¹,Ravichander M.³

Affiliation:

1. Department of Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories, Hyderabad, India

2. Department of Chemistry, Jawaharlal Nehru Technological University, Hyderabad, India

3. Department of Chemistry, Mahatma Gandhi Institute of Technology, Hyderabad, India

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pharmaceutical Science,Biochemistry,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826076.2015.1087861

Reference117 articles.

1. Four Phase III Trials Confirm Benefits of BI’s Oral, Once-Daily Type 2 Diabetes Therapy.Genet. Eng. Biotechnol. News. 2010.

2. Spreitzer, H. Neue Wirkstoffe - BI-1356 (in German). Österreichische Apothekerzeitung(18/2008). 2008, 918.

3. BI-1356

4. Once-daily MIRAPEX ER now approved by FDA for both early and advanced Parkinson’s disease. Boehringer Ingelheim Pharmaceuticals, Inc. Retrieved 19 December 2013.

5. National Prescribing Service. (2009). Pramipexole for Parkinson’s Disease. Medicines Update. http://www.nps.org.au/consumers/publications/medicine_update/issues/Pramipexole_for_Parkinsons_disease.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques;International Journal of Molecular Sciences;2024-02-23

2. Isolation, Characterization and Cumulative Quantification approach for nine organic impurities in empagliflozin and linagliptin drugs;Indian Journal of Chemical Technology;2024

3. Investigation of an artificial solution degradant of linagliptin: An undesired linagliptin urea derivative generates in sample preparation of linagliptin tablet treated by sonication in acetonitrile containing diluent;Journal of Pharmaceutical and Biomedical Analysis;2022-02

4. A New Stability Indicating Reverse Phase HPLC Method for the Determination of Related Substances of DPP4 Inhibitor Drug: Linagliptin;Asian Journal of Chemistry;2022

5. Determination of Anti‐Parkinson Drug Pramipexole Using a Label‐free Biosensor and Evaluation of its Interaction with ds‐DNA;Electroanalysis;2021-12-07